GT Biopharma, Inc. (GTBP) stock
GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.43+0.25 (+7.86%)
Close on Nov 18, 2026Market cap $154.73MP/E –Yield –
GT Biopharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
GT Biopharma's price to book ratio was 17.4× on Nov 11, 2026, against 39.8× a year earlier. Over the last 5 years it ranged from 13.9× to 481.8×, with a median of 45.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 17.4× | −22.2 |
| 2025 | Dec 31, 2025 | 39.6× | −41.6 |
| 2024 | Dec 31, 2024 | 81.2× | +54.8 |
| 2023 | Dec 29, 2023 | 26.4× | −18.9 |
| 2022 | Dec 30, 2022 | 45.3× | −377.2 |
| 2019 | Oct 31, 2019 | 422.6× | +292.7 |
| 2018 | Oct 31, 2018 | 129.9× | −241.2 |
| 2017 | Dec 29, 2017 | 371.0× | – |
See a number that looks wrong?